Natus Medical Cash and Equivalents USD Trend

Natus Medical Incorporated -- USA Stock  

USD 31.20  0.50  1.63%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Cash and Equivalents USD of Natus Medical Incorporated with missing and latest data points interpolated. Cash and Equivalents in USD, converted by [FXUSD].
Cash and Equivalents USD  10 Years Trend  
Increasing
Slightly volatile
 Cash and Equivalents USD 
      Timeline 

Natus Medical Cash and Equivalents USD Over Time

2016-12-31  213,551,000 
2017-12-31  213,551,000 
2018-12-31  155,800,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  77,235,308
Geometric Mean  53,784,845
Coefficient Of Variation  91.62
Mean Deviation  54,835,349
Median  56,106,000
Standard Deviation  70,763,885
Range  201,635,000
R Value  0.80
R Squared  0.64
Significance  0.001097
Slope  14,487,374

Currently Trending

V   
 NYQ 
Sold over 20 shares of
a day ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
a day ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
a day ago ago
Traded for 10.61